Asian Industry Groups Push For Universal Care, E-Labeling, Flexible Supply Chain

Joint Assessment Progressing

An annual meeting of Asian pharma industry groups in Tokyo recognized the need for faster joint regulatory allowance for second suppliers to stabilize the supply chain, drive e-labeling for patients and expand universal healthcare to better cover expensive therapeutics.

Asian industry groups and regulatory authorities held the 13th annual meeting in Tokyo.
Asian industry groups and regulatory authorities hold 13th annual APAC meeting in Tokyo • Source: Shutterstock

The latest annual conference of pharmaceutical industry groups in Asia kept a strong focus on the importance of universal healthcare coverage (UHC), while also stressing the importance of collaboration on regulatory systems and drug discovery.

Other initiatives such as the allowance of second suppliers to help stabilize supply chains and wider use of e-labelling also engaged participants at the 13th Asia Partnership Conference of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Drug Safety

More from Pink Sheet